1036724-54-5Relevant articles and documents
2-AZABICYCLO HEXANE JAK INHIBITOR COMPOUND
-
Paragraph 0155, (2020/05/14)
The invention provides a compound of formula 1 or a pharmaceutically-acceptable salt thereof, that is useful as a JAK inhibitor. The invention also provides pharmaceutical compositions comprising the compound, methods of using the compound to treat diseas
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND
-
Paragraph 0204-0205, (2018/11/21)
The invention provides a compound of formula 1 or a pharmaceutically-acceptable salt thereof, that is useful as a JAK inhibitor. The invention also provides crystalline forms of the compound, pharmaceutical compositions comprising the compound, methods of using the compound to treat diseases amenable to a JAK inhibitor, and processes and intermediates useful for preparing the compound.
Regioselectivity of fluorine substitution by alkoxides on unsymmetrical difluoroarenes
Dirr, Ronan,Anthaume, Cyril,Désaubry, Laurent
, p. 4588 - 4590 (2008/09/21)
An efficient approach to unsymmetrical halogenated resorcinol diethers has been developed. This synthesis consists of two subsequent nucleophilic aromatic substitutions (SNAr) of unsymmetrical difluoroarenes by alkoxides. The novelty of this ap
FLUOROIMIDAZOPYRIMIDINES AS GABA-A ALPHA 2/3 LIGANDS FOR DEPRESSION/ANXIETY
-
Page 47, (2010/02/07)
The present invention provides a compound formula (I), or a pharmaceutically acceptable salt thereof: wherein W is phenyl or pyridyl; X1 represents hydrogen, halogen, C1-6 alkyl, trifluoromethyl or C1-6 alkoxy; X2/su